Anti-FAP Antibody (Sibrotuzumab)
Catalog No.
F1357
Anti-FAP Antibody (Sibrotuzumab)
Featured Products
Sibrotuzumab (BIBH 1) is a humanized IgG1 monoclonal antibody targeting fibroblast activation protein (FAP). Sibrotuzumab is being investigated in colorectal cancer and non-small cell lung cancer.
Quality Control & DataSheet
- View current batch:
-
Purity > 95% by SDS-PAGE and SEC-HPLC analyses.
- MSDS (Material Safety Data Sheet)
- Datasheet
148.66 kDa
Dry ice
216669-97-5
-80°C
2 years
Liquid
See label
For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.
CHO
BIBH 1, humanized F19
100 mM Pro 20 mM Arg pH 5.0. No preservative!
Q12884
Human
Unconjugated
Monoclonal
Protein A
IgG1
ELISA, FACS, Kinetics, Functional assay, Animal Model
Immobilized human FAP His at 2 ug/mL can bind Anti-FAP Antibody (Sibrotuzumab)
FAP
Please avoid freeze-thaw cycles.